- Featured Product
- KD/KO Validated
TMEM106B (1-46aa) Monoclonal antibody
TMEM106B (1-46aa) Monoclonal Antibody for WB, IP, ELISA
Host / Isotype
Mouse / IgG1
Reactivity
human
Applications
WB, IF, IP, ELISA
Conjugate
Unconjugated
CloneNo.
5D1F8
Cat no : 60333-1-Ig
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | U2OS cells, HeLa cells, K-562 cells, LNCaP cells, A549 cells, Jurkat cells |
Positive IP detected in | HeLa cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
KD/KO | See 2 publications below |
WB | See 5 publications below |
IF | See 1 publications below |
IP | See 1 publications below |
Product Information
60333-1-Ig targets TMEM106B (1-46aa) in WB, IF, IP, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Cited Reactivity | human |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | TMEM106B (1-46aa) fusion protein Ag21448 |
Full Name | transmembrane protein 106B |
Calculated Molecular Weight | 31 kDa |
Observed Molecular Weight | ~40 kDa |
GenBank Accession Number | BC033901 |
Gene Symbol | TMEM106B |
Gene ID (NCBI) | 54664 |
RRID | AB_2881442 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TMEM106B is a genetic risk factor for frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP). Amyotrophic lateral sclerosis (ALS), like FTLD-TDP, is characterized by pathological TDP-43 inclusions. TMEM106B expression in the brain may be linked to mechanisms of disease in FTLD-TDP and risk alleles confer genetic susceptibility by increasing gene expression.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for TMEM106B (1-46aa) antibody 60333-1-Ig | Download protocol |
IP protocol for TMEM106B (1-46aa) antibody 60333-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Brain C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes | ||
Pathol Res Pract TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma | ||
F1000Res The identification of high-performing antibodies for transmembrane protein 106B (TMEM106B) for use in Western blot, immunoprecipitation, and immunofluorescence
| ||
FASEB J Lysosomal membrane protein TMEM106B modulates hematopoietic stem and progenitor cell proliferation and differentiation by regulating LAMP2A stability | ||
Acta Neuropathol Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging |